Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

New therapies like JAK inhibitors and stem cells show promise for treating vitiligo.

The hair follicle infundibulum plays a key role in skin health and disease, and understanding it better could lead to new skin disease treatments.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

Enhancing antioxidant responses can improve treatments for various diseases.

Some cases of tinea capitis, a fungal scalp infection, can look like scarring hair loss due to the body's immune response and the fungus itself.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Low vitamin D may increase autoimmune thyroid disease risk, but its treatment effects are unclear.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Menopause-related skin changes may increase fungal infections and inflammation.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Severe acne patients have higher inflammatory markers than healthy people.

Baricitinib is a safe and effective treatment for alopecia areata, with better results in patients with lower initial severity, shorter disease duration, and longer treatment.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

A young woman with late-stage Vogt-Koyanagi-Harada disease was successfully treated at a hospital.

Low energy laser therapy effectively treats certain skin conditions and improves recovery time without side effects.

Fractional lasers seem effective and safe for treating hair loss, but more research is needed to find the best treatment methods.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

IL-1 blockade is effective for treating SURF, and personalized treatment is needed.

Certain genes may be linked to autoimmune conditions in people with alopecia areata.

PCOS involves immune and genetic factors, with key roles for T cells and specific genes.

Diet and lifestyle changes can help manage autoimmune diseases by reducing inflammation and supporting immune health.